| dc.contributor.author | Williams, B | en_US |
| dc.contributor.author | MacDonald, TM | en_US |
| dc.contributor.author | Morant, S | en_US |
| dc.contributor.author | Webb, DJ | en_US |
| dc.contributor.author | Sever, P | en_US |
| dc.contributor.author | McInnes, G | en_US |
| dc.contributor.author | Ford, I | en_US |
| dc.contributor.author | Cruickshank, JK | en_US |
| dc.contributor.author | Caulfield, MJ | en_US |
| dc.contributor.author | Salsbury, J | en_US |
| dc.contributor.author | Mackenzie, I | en_US |
| dc.contributor.author | Padmanabhan, S | en_US |
| dc.contributor.author | Brown, MJ | en_US |
| dc.contributor.author | British, HSPATHWAYS | en_US |
| dc.date.accessioned | 2017-02-03T17:04:28Z | |
| dc.date.issued | 2015-11-21 | en_US |
| dc.date.submitted | 2017-01-21T14:36:36.418Z | |
| dc.identifier.issn | 0140-6736 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/19182 | |
| dc.description.sponsorship | British Heart Foundation and National Institute for Health Research. | en_US |
| dc.format.extent | 2059 - 2068 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | LANCET | en_US |
| dc.rights | Open Access article distributed under the terms of CC BY | |
| dc.title | Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial | en_US |
| dc.type | Article | |
| dc.rights.holder | © Williams et al. | |
| dc.identifier.doi | 10.1016/S0140-6736(15)00257-3 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365987600027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 10008 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 386 | en_US |
